An FDA panel supports Merck COVID drug in mixed vote
If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.
Pharmaceuticals
For Those Facing Alzheimer's, A Controversial Drug Offers Hope
A plaque-busting Alzheimer's drug called Aduhelm has yet to prove it can preserve memory and thinking. Even so, its approval by the Food and Drug Administration is making some patients opitimistic.
An Alzheimer's Drug May Boost Cognition In People With Fragile X Syndrome
An experimental medicine seems to ease symptoms of Fragile X syndrome, a genetic disorder that is the most common inherited cause of intellectual disabilities and autism.
Antibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges
Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.
After A Year Battling COVID-19, Drug Treatments Get A Mixed Report Card
Drugs for COVID-19 are sorted into three basic categories: They work, they don't work, or there simply isn't enough information to know. A generic steroid is one medicine that proved helpful.
FDA Approves First Drug For A Rapid Aging Disorder In Children
A newly approved drug can extend the lives of children with progeria, a rare disorder that causes rapid aging. The drug is the result of one family's effort to help a child with the fatal condition.
Amazon Wants To Sell You Prescription Medications
Amazon launches an online pharmacy, sending shares of CVS, Walgreens and Rite Aid tumbling. Amazon has pushed to compete with Walmart and major pharmacy chains that have long offered home delivery.
FDA OKs Eli Lilly COVID-19 Drug, But Supplies Will Be Limited
Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.
Federal Supply Deal For COVID-19 Antibody Treatment Lacks Some Customary Protections
To boost the supply of Regeneron's antibody therapy for COVID-19, the federal government entered into a $450 million supply contract. Details of the deal show some safeguards are missing.
How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated?
Experimental medicines have the potential to help people with COVID-19 avoid hospitalization. The scarce supply of the treatments would have to be rationed, if regulators OK their use.